It may overdrive metabolic processes initially
This meant GLP-1 would need to be given in high doses if it was to have any therapeutic potential
Children and adolescents: The safety profile of these peptides in developing bodies has not been established
In addition, in a rat model of IBS, intraperitoneal administration of exendin-4 normalized stress-induced defecation and visceral pain sensitivity, without affecting centrally regulated anxiety-like behaviors [56]
The growth of the market is driven by rising global obesity rates, increased focus on innovative pharmacological treatments like GLP-1 receptor agonists , and expanding investments in lifestyle and surgical intervention research
Nicholls SJ, Tuzcu EM, Kalidindi S, Wolski K, Moon KW, Sipahi I, et al